Banner

Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023– By Product (Antiparasitic, Anti-Infectives, Vaccines, NSAIDs), By Service Type (In House, Contract Outsourcing), By Synthesis Type (Chemical Based API, Biological API, Highly Potent API)– Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


Veterinary active pharmaceutical ingredients manufacturing refers to API synthesis from raw materials that necessitates multi-step methods using a range of high-tech processing technologies.

The main products of veterinary active pharmaceutical ingredients manufacturing are anti-infectives, vaccines, and nsaids. Chemical-based API refers to the active ingredients of pharmaceutical medicine that have the desired impact on the body in order to cure a disease. The various service types involved are in-house and contract outsourcing, and various synthetic types involve chemical based API, biological API, and highly potent API.

The veterinary active pharmaceutical ingredients manufacturing market research report is one of a series of new reports from The Business Research Company that provides veterinary active pharmaceutical ingredients manufacturing market statistics, including veterinary active pharmaceutical ingredients manufacturing industry global market size, regional shares, competitors with veterinary active pharmaceutical ingredients manufacturing market share, detailed veterinary active pharmaceutical ingredients manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary active pharmaceutical ingredients manufacturing industry. This veterinary active pharmaceutical ingredient manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to grow from $6.37 billion in 2022 to $6.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary active pharmaceutical ingredients manufacturing market size is expected to grow to $9.11 billion in 2027 at a CAGR of 7.3%.

The increasing number of pet owners is expected to propel the growth of the veterinary active pharmaceutical ingredients manufacturing market going forward. Pet owners are individuals who own or adopt a pet animal. The pet owners provide necessary health facilities to the pets which increases the demand for veterinary drugs. For instance, according to the South China Morning Post, a Hong Kong-based English-language newspaper, pet owners in China reached 62.94 million in 2020, up from 62.8 million in 2019. Therefore, increasing pet ownership is driving demand for the veterinary active pharmaceutical ingredients manufacturing market.

Product innovation is a key trend gaining popularity in the veterinary active pharmaceutical ingredient manufacturing market. Major players in the market are focusing on innovative products to sustain their market positions. For instance, in June 2021, Lasa Supergenerics Limited, an India-based active pharmaceutical ingredient (API) manufacturing company, launched Oxyclozanide. Oxyclozanide is a novel anthelmintic that treats and manages fascioliasis, a topical worm infection in ruminants, primarily domestic animals like cattle (particularly buffalos on farms), goats, and sheep. Oxyclozanide is frequently used in the veterinary industry and has enormous potential in domestic and international markets.

In June 2022, Orion Corporation, a Finland-based human and veterinary pharmaceutical industry, acquired Inovet (V.M.D. nv/sa) for an amount of $128.33 million (130 million euros). Through this acquisition, Orion's Veterinary Medicines section will broaden its product portfolio and obtain a foothold in the production animal market, as well as extend its geographical footprint in Western Europe and the export market. Inovet (V.M.D. nv. sa.) is a Belgium-based manufacturer of veterinary active pharmaceutical ingredients.

Major players in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group, Menadiona SL, Afton Pharma, Jiangsu Lingyun Pharmaceutical Co Limited, SUANFARMA, NGL Fine-Chem Limited, FIS Fabbrica Italiana Sintetici SpA, Lupin Limited, Aurobindo Pharma Limited, Albemarle Corporation, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, and Divi's Laboratories Limited.

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2022. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the veterinary active pharmaceutical ingredients manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The veterinary active pharmaceutical ingredients manufacturing market consists of revenues earned by entities by biologics and bulk drugs that are used to create components in medications which are responsible for the positive veterinary health impacts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global veterinary active pharmaceutical ingredients manufacturing market is segmented -

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, and NSAIDs

2) By Service Type: In-House, Contract Outsourcing

3) By Synthesis Type: Chemical-Based API, Biological API, Highly Potent API

    Table Of Contents

    1. Executive Summary

    2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Characteristics

    3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends And Strategies

    4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Veterinary Active Pharmaceutical Ingredients Manufacturing Market

    4.2. Ukraine-Russia War Impact On Veterinary Active Pharmaceutical Ingredients Manufacturing Market

    4.3. Impact Of High Inflation On Veterinary Active Pharmaceutical Ingredients Manufacturing Market

    5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size And Growth

    5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmentation

    6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Antiparasitic

    Anti-Infectives

    Vaccines

    NSAIDs

    6.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    In House

    Contract Outsourcing

    6.3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Chemical Based API

    Biological API

    Highly Potent API 

    7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Regional And Country Analysis

    7.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    8.1. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    9.1. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview  

    9.2. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    10.1. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    11.1. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    12.1. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    13.1. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    14.1. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    15.1. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    15.2. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    16.1. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    17.1. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    18.4. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    19.1. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    19.2. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    20.1. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    21.1. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    21.2. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    22.1. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    22.2. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    23.1. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    23.2. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    24.1. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    25.1. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    25.2. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market  

    26.1. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview

    26.2. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape And Company Profiles

    27.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape

    27.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Company Profiles

    27.2.1. Alivira Animal Health Limited

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Excel Industries Limited

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Ofichem Group

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Menadiona SL

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Afton Pharma

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market

    29. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Alivira Animal Health Limited Financial Performance
  • Table 47: Excel Industries Limited Financial Performance
  • Table 48: Ofichem Group Financial Performance
  • Table 49: Menadiona SL Financial Performance
  • Table 50: Afton Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Alivira Animal Health Limited Financial Performance
  • Figure 47: Excel Industries Limited Financial Performance
  • Figure 48: Ofichem Group Financial Performance
  • Figure 49: Menadiona SL Financial Performance
  • Figure 50: Afton Pharma Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report